Oral cancer - kliniske og patobiologiske aspekter
- Prosjektnummer
- SFP891-09
- Ansvarlig person
- Lars Uhlin-Hansen
- Institusjon
- Universitetet i Tromsø
- Prosjektkategori
- Flerårig forskningsprosjekt
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 1. Underpinning
The proteoglycan repertoire of lymphoid cells.
Glycoconj J 2012 Oct;29(7):513-23. Epub 2012 jul 10
PMID: 22777011
Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive front.
Eur J Cancer 2011 Jan;47(2):305-15.
PMID: 20932741
Regulation of matrix metalloproteinase activity in health and disease.
FEBS J 2011 Jan;278(1):28-45. Epub 2010 nov 19
PMID: 21087458
S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment.
Am J Pathol 2011 May;178(5):2389-96.
PMID: 21514449
Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity.
J Histochem Cytochem 2010 Jan;58(1):29-39. Epub 2009 sep 15
PMID: 19755718
Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.
Virchows Arch 2010 Dec;457(6):677-92. Epub 2010 okt 3
PMID: 20890764
The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.
BMC Cancer 2009;9():183. Epub 2009 jun 15
PMID: 19527490
Oral squamous cell carcinoma,- matrix metalloproteinases, S100A4, and role of tumor-stroma interactions
- Disputert:
- april 2011
- Hovedveileder:
- Thrina Loennechen
Oral and Skin Squamous Cell Carcinomas. Role of the Microenvironment in Tumor Progression
- Disputert:
- februar 2010
- Hovedveileder:
- Lars Uhlin-Hansen
Expression and activity of NADPH oxidases and the ROS-mediated effects on gamma-Glutamyltransferase expression in cancer cells
- Disputert:
- desember 2010
- Hovedveileder:
- Gunbjørg Svineng
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord